Further research has revealed that GZMA interacts with the F2R receptor on the surface of tumor cells, activating the JAK2/STAT1 signaling pathway, inducing tumor cell apoptosis, and T cell-mediated tumor killing. The gene discussed is JAK2; the disease is neoplasm.